Goldman Sachs’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-199,477
| Closed | -$3.02M | – | 5726 |
|
|
2019
Q4 | $3.02M | Buy |
199,477
+79,322
| +66% | +$685K | ﹤0.01% | 3347 |
|
|
2019
Q3 | $768K | Sell |
120,155
-30,865
| -20% | -$258K | ﹤0.01% | 4194 |
|
|
2019
Q2 | $1.44M | Buy |
151,020
+50,662
| +50% | +$546K | ﹤0.01% | 3750 |
|
|
2019
Q1 | $1.36M | Sell |
100,358
-3,417
| -3% | -$28.5K | ﹤0.01% | 3879 |
|
|
2018
Q4 | $746K | Buy |
103,775
+14,523
| +16% | +$159K | ﹤0.01% | 4145 |
|
|
2018
Q3 | $973K | Sell |
89,252
-67,815
| -43% | -$684K | ﹤0.01% | 4071 |
|
|
2018
Q2 | $1.45M | Sell |
157,067
-78,918
| -33% | -$736K | ﹤0.01% | 3837 |
|
|
2018
Q1 | $1.89M | Buy |
235,985
+68,395
| +41% | +$1.49M | ﹤0.01% | 3645 |
|
|
2017
Q4 | $4.66M | Sell |
167,590
-6,620
| -4% | -$176K | ﹤0.01% | 3066 |
|
|
2017
Q3 | $4.7M | Buy |
174,210
+36,955
| +27% | +$967K | ﹤0.01% | 3207 |
|
|
2017
Q2 | $4M | Sell |
137,255
-9,488
| -6% | -$288K | ﹤0.01% | 3246 |
|
|
2017
Q1 | $5M | Sell |
146,743
-32,023
| -18% | -$1.03M | ﹤0.01% | 2935 |
|
|
2016
Q4 | $5.42M | Sell |
178,766
-112,901
| -39% | -$3.64M | ﹤0.01% | 2979 |
|
|
2016
Q3 | $9.86M | Buy |
291,667
+193,170
| +196% | +$6.22M | ﹤0.01% | 2459 |
|
|
2016
Q2 | $2.88M | Buy |
98,497
+78,077
| +382% | +$2.15M | ﹤0.01% | 3308 |
|
|
2016
Q1 | $422K | Buy |
20,420
+592
| +3% | +$14.5K | ﹤0.01% | 4918 |
|
|
2015
Q4 | $686K | Buy |
19,828
+4,747
| +31% | +$136K | ﹤0.01% | 4645 |
|
|
2015
Q3 | $352K | Sell |
15,081
-29,401
| -66% | -$714K | ﹤0.01% | 5465 |
|
|
2015
Q2 | $781K | Sell |
44,482
-22,135
| -33% | -$341K | ﹤0.01% | 4762 |
|
|
2015
Q1 | $1.02M | Sell |
66,617
-52,464
| -44% | -$882K | ﹤0.01% | 4455 |
|
|
2014
Q4 | $2.16M | Buy |
+119,081
| New | +$1.99M | ﹤0.01% | 3762 |
|
Goldman Sachs's DERM Position: Q1 2020 in Review
Goldman Sachs sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 199,477 shares — an estimated $3.02M sold.
Goldman Sachs first reported a position in DERM in Q4 2014 and held it in 21 quarters. The position peaked at $9.86M in Q3 2016. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Goldman Sachs reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Goldman Sachs sold 199,477 Dermira, Inc. shares in Q1 2020, an estimated $3.02M.
- Goldman Sachs first reported a position in Dermira, Inc. in Q4 2014 and held it in 21 quarters.
- Goldman Sachs's Dermira, Inc. position peaked at $9.86M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.